Treatment of Sleep Disorders with Neurofeedback
Not Applicable
- Conditions
- Sleep Disorders.Sleep disorders
- Registration Number
- IRCT20190620043954N1
- Lead Sponsor
- Iran National Science Foundation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Having at least 18 years and maximum 50 years
Ability to read and write
Lack of psychotic disorders based on clinical interviews
No use of hypnotic drugs
A change of dose and the type of psychiatric medications of two months before entering the project until to end of the follow up period
Not having history of Seizure
Diagnostics one type of sleep disorders according to interviews and questionnaire
Exclusion Criteria
Lack of desire to continue treatment
Treatmenting ECT fromentering of the project to follow up period
To use of hypnotic drugs from entering of the project to end of follow up period
Having seizures from entering of the project to follow up period
Exacerbation of symptoms of HIV that they may not continue to the project
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Measurement of sleep quality. Timepoint: Before the onset of treatment and two weeks after starting treatment. Method of measurement: Pittsburgh Sleep Quality Index.
- Secondary Outcome Measures
Name Time Method Improvement of sleep quality. Timepoint: Early (before the onset of treatment)and the end of the study (after the end of treatment). Method of measurement: Polysomnography.;Interrupted sleep. Timepoint: Early (before the onset of treatment)and the end of the study (after the end of treatment). Method of measurement: Polysomnography.;Time to fall asleep. Timepoint: Early (before the onset of treatment)and the end of the study (after the end of treatment). Method of measurement: Polysomnography.;Restless leg syndrome. Timepoint: Early (before the onset of treatment)and the end of the study (after the end of treatment). Method of measurement: Polysomnography.;Improving the quality of life. Timepoint: Early (before the onset of treatment)and the end of the study (after the end of treatment). Method of measurement: HIV/AIDS – Quality of Life (HAT-QoL) questionnaire.